Moderna Begins Clinical Trial of COVID-19 Vaccine for Ages 6 Months to 11 Years

[Image source=Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] Moderna has begun clinical trials of its COVID-19 vaccine targeting infants and young children.

On the 16th (local time), according to CNN and The Wall Street Journal, Moderna announced in a statement that "clinical trials have started in the United States and Canada involving 6,750 children aged from 6 months to 11 years."

The clinical trial will proceed in two phases. Moderna plans to administer different dosages and then observe safety and immune system responses.

The U.S. Department of Health and the National Institute of Allergy and Infectious Diseases (NIAID) are also participating in this clinical trial. The Wall Street Journal reported, "Government officials expect that if this clinical trial is successful, vaccinations for middle and high school students could begin this fall, and for elementary school students early next year."

Pfizer is currently conducting clinical trials involving 2,259 individuals aged 12 to 15. They also plan to soon conduct trials for children aged 5 to 11. Johnson & Johnson has announced plans to conduct clinical trials targeting those aged 12 to 18.

This content was produced with the assistance of AI translation services.